Homology Medicines, Inc.

NasdaqGS:FIXX Stock Report

Mkt Cap: US$87.9m

Homology Medicines Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure

CEO

Albert Seymour (54 yo)

0.33yr

Tenure

US$1,467,658

Compensation

Dr. Albert Seymour, Ph D., serves as Chief Executive Officer & Director of Homology Medicines, Inc. since September 2022. He had been the Chief Scientific Officer of Homology Medicines, Inc. since April 20...

CEO Compensation Analysis

How has Albert Seymour's remuneration changed compared to Homology Medicines's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$1m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$1mUS$450k

-US$96m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$90m

Mar 31 2021n/an/a

-US$94m

Dec 31 2020US$608kUS$427k

-US$129m

Sep 30 2020n/an/a

-US$123m

Jun 30 2020n/an/a

-US$124m

Mar 31 2020n/an/a

-US$115m

Dec 31 2019US$2mUS$406k

-US$104m

Sep 30 2019n/an/a

-US$99m

Jun 30 2019n/an/a

-US$83m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$2mUS$387k

-US$56m

Sep 30 2018n/an/a

-US$49m

Jun 30 2018n/an/a

-US$41m

Mar 31 2018n/an/a

-US$35m

Dec 31 2017US$756kUS$361k

-US$30m

Compensation vs Market: Albert's total compensation ($USD1.47M) is above average for companies of similar size in the US market ($USD727.78K).

Compensation vs Earnings: Albert's compensation has increased whilst the company is unprofitable.

Leadership Team

NamePositionTenureCompensationOwnership
Albert Seymour
Chief Executive Officer0.75yrUS$1.47m0.26%
$ 226.0k
W. Smith
CFO, Treasurer & Chief Business Officer5.75yrsUS$2.05m0.025%
$ 21.8k
Saswati Chatterjee
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Julie Jordan
Senior VP and Head of Clinical Development & Operations0.83yrno datano data
Paul Alloway
Chief Legal Officer & Secretary2.58yrsno data0.029%
$ 25.6k
Theresa McNeely
Chief Communications Officer & Patient Advocateno datano datano data
Melissa Gelormini
Vice President of Human Resources3yrsno datano data
Michael Blum
Chief Commercial Officer3yrsno data0.016%
$ 14.4k
Deborah Kinch
Chief Development Officer1yrno datano data

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: FIXX's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Albert Seymour
Chief Executive Officer0.33yrUS$1.47m0.26%
$ 226.0k
Saswati Chatterjee
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Steven S. Gillis
Independent Director7yrsUS$121.49k0%
$ 0
Matthew Patterson
Independent Director5yrsUS$120.99k0%
$ 0
Beverly Davidson
Chairman of Scientific Advisory Board5yrsno datano data
Mary Thistle
Independent Director4.83yrsUS$128.49k0%
$ 0
Richard James Gregory
Independent Director8yrsUS$118.49k0.019%
$ 16.5k
Mason Freeman
Member of Scientific Advisory Boardno datano datano data
Morton Cowan
Member of Scientific Advisory Boardno datano datano data
Stephen Elledge
Member of Scientific Advisory Boardno datano datano data
Arthur Tzianabos
Chairman of the Board6.75yrsUS$3.61m0.19%
$ 165.8k
Hans-Peter Kiem
Member of Scientific Advisory Boardno datano datano data

5.0yrs

Average Tenure

62yo

Average Age

Experienced Board: FIXX's board of directors are considered experienced (5 years average tenure).